Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies

Stopping immunosuppression in a transplant patient with donor-derived malignancy offers the theoretical benefit that reconstitution of the patient’s immune system will allow “rejection” of the malignancy, as the malignancy also originates from allogeneic tissue. However, this option exists with the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transplant Direct
Autors principals: Amara, Dominic, Wisel, Steven A., Braun, Hillary J., Collisson, Eric A., Friedlander, Terence, Worner, Giulia, Roll, Garret R., Hirose, Ryutaro, Stock, Peter G.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
Pancreas and Islet Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725258/
https://ncbi.nlm.nih.gov/pubmed/33324741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001090
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars